What can research evidence tell us about Monkeypox Outbreak? Rapid Evidence Review

Authors

  • Tesfaye Dagne Ethiopian Public Health Institute Author
  • Dagmawit Solomon Ethiopian Public Health Institute Author
  • Firmaye Bogale Ethiopian Public Health Institute Author
  • Yosef Gebreyohannes Ethiopian Public Health Institute Author
  • Sabit Ababor Ethiopian Public Health Institute Author
  • Zelalem Kebede Ethiopian Public Health Institute Author
  • Samson Mideksa Ethiopian Public Health Institute Author
  • Mamuye Hadis Ethiopian Public Health Institute Author
  • Desalegn Ararso Ethiopian Public Health Institute Author
  • Ermias Woldie Ethiopian Public Health Institute Author
  • Tsegaye Getachew Ethiopian Public Health Institute Author
  • Getachew Tollera Ethiopian Public Health Institute Author

DOI:

https://doi.org/10.20372/ejphn.V7i2.249

Abstract

Key Findings

Monkey pox (MPX) has similar virus family and symptoms with that of smallpox.

  • The symptoms of monkeypox includes fever, headache, muscle aches, backache, swollen lymph nodes, chills, exhaustion, rash that occurs on the face, within the mouth, hands, feet, chest, genitals, or anus.

  • Males make up of more than half of monkeypox cases in most outbreaks.

  • People who had received a smallpox vaccination had a lower overall attack rate than those who didn’t received a smallpox vaccination.

  • According to the WHO the case fatality rate (CFR) for monkeypox was 3 – 6% and all deaths were among unvaccinated against smallpox.

  • Human to human transmission of monkey pox includes, sharing a room or bed, living in the same house, and drinking or eating from the same dish with infected individual.

  • Avoiding coming into close, skin-to-skin contact with the monkey pox infected individual, washing hands frequently or use an alcohol-based hand sanitizer, not handling or touching the bedding, towels, or clothing of a sick person, avoiding contact with rodents, primates and other animals, etc were methods identified for prevention of monkey pox.

  • Tecorivimat which is developed for treating orthopoxvirus associated infection may be used for tratment of monkypox virus and vaccination may be considered.

Downloads

Download data is not yet available.

Author Biographies

  • Tesfaye Dagne, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Dagmawit Solomon, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Firmaye Bogale, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa,  Ethiopia

  • Yosef Gebreyohannes, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Sabit Ababor, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Zelalem Kebede, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Samson Mideksa, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Mamuye Hadis, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Desalegn Ararso, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Ermias Woldie, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Tsegaye Getachew, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

  • Getachew Tollera, Ethiopian Public Health Institute

    Ethiopian Public Health Institute, Addis Ababa, Ethiopia

References

African CDC (2022). Press Release on Monkeypox situation in Africa. Available at: https://africacdc. org/news-item/press-release-on-monkeypox-situation-in-africa/.

Beer EM & Bhargavi RV (2019). A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Neglected Tropical Diseases, 13(10): 1–20. doi: 10.1371/journal.pntd.0007791.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR & Steffen R (2022). The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Neglected Tropical Diseases, 16(2):1–20.doi:10.1371/journal. pntd.0010141.

CDC (2022a). 2022 Monkeypox Outbreak Global Map. Available at: https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html.

CDC (2022b). 2022 U.S. Monkeypox Outbreak.Available at:https://www.cdc.gov/poxvirus/monkeypox/prevention.html.

CDC (2022c). About Monkeypox. Available at:https://www.cdc.gov/poxvirus/monkeypox/about.html.

CDC (2022d). Considerations for Monkeypox Vaccination. Available at: https://www.cdc.gov/poxvirus/monkeypox/considerations-for-monkeypox-vaccination.html.

Damon IK (2012). Smallpox, Monkeypox, and Other Poxvirus Infections. Twenty Fou, Goldman’s Cecil Medicine: Twenty Fourth Edition. Twenty Fou. Elsevier Inc. doi: 10.1016/B978-1-4377-1604-7.00380-8.

Ethiopian Public Health Institute (EPHI) & PHEOC. (2022). Monkeypox Outbreak Update. Addis Ababa.

Jamieson DJ, Cono J, Richards CL & Treadwell TA (2004). The role of the obstetrician-gynecologist in emerging infectious diseases. Monkeypox and pregnancy. Obstetrics and Gynecology, 103(4): 754–756. doi: 10.1097/01.AOG.0000114987.76424.6d.

Overton ET, Lawrence S, Stapleton J, Weidenthaler H, Schmidt D & Nopora K. et al. (2020). MVA-BN as monkeypo, vaccine for healthy and immunocompromised. International Journal of Infectious Diseases, 101, p. 464. doi: 10.1016/j.ijid.2020.09.1217.

Radonić A, Metzger S, Dabrowski PW, Couacy-Hymann E, Schuenadel L & Kurth A, et al. (2014). Fatal monkeypox in wild-living sooty mangabey, Côte d’Ivoire, 2012. Emerging Infectious Diseases, 20(6): 1009–1011. doi: 10.3201/eid2006.131329.

WHO (2022a). 2022 Monkeypox Outbreak: Global Trends. Available at: https://worldhealthorg.shinyapps.io/mpx_global/.

WHO (2022b). Monkeypox Key Fact sheet. Available at: https://www.who.int/news-room/fact-sheets/detail/monkeypox.WHO (2022c). Monkeypox outbreak toolbox. Available at: https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/monkeypox-outbreak-toolbox#:~:text=WHO suggested outbreak case definition,or more acute skin lesions.

WHO (2022d). Multi-country monkeypox outbreak: situation update. WHO (2022e). WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. Available at: https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern.

Downloads

Published

2024-07-31

Issue

Section

Rapid evidence review

Categories

How to Cite

Dagne, T. et al. (2024) “What can research evidence tell us about Monkeypox Outbreak? Rapid Evidence Review”, Ethiopian Journal of Public Health and Nutrition (EJPHN), 7(2), pp. 121–127. doi:10.20372/ejphn.V7i2.249.

Most read articles by the same author(s)

1 2 3 > >>